• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CA-125、胎盘碱性磷酸酶和组织多肽抗原作为卵巢癌术前血清标志物

CA-125, placental alkaline phosphatase and tissue polypeptide antigen as preoperative serum markers in ovarian carcinoma.

作者信息

Toftager-Larsen K, Hørding U, Dreisler A, Daugaard S, Lund B, Bock J, Lundvall F, Frederiksen K, Nørgaard-Pedersen B

机构信息

Department of Gynaecology and Obstetrics, Herlev Hospital, Copenhagen, Denmark.

出版信息

Gynecol Obstet Invest. 1992;33(3):177-82. doi: 10.1159/000294876.

DOI:10.1159/000294876
PMID:1319386
Abstract

Blood samples were drawn before laparotomy in 42 cases of benign, 17 cases of borderline, and 53 cases of malignant epithelial ovarian neoplasms. The concentrations of CA-125, tissue polypeptide antigen, and placental alkaline phosphatase (PLAP) were determined. No significant difference was found between the levels of CA-125 and TPA. No significant correlation was seen between tumour type and these two markers; however, both were significantly correlated to tumour malignancy and clinical stage, and CA-125 was also correlated to tumour grade. No correlation was found between PLAP and the other markers or any of the above-mentioned parameters. If at least one of two or three markers was requested to be positive, a moderate increase in the 'detection rate' of malignant tumours was found. However, the rate of positive benign samples increased to as much as 41%. Requesting at least two markers out of two or three to be positive certainly reduced the number of 'false-positive' benign tumours, but the sensitivity for malignant tumours was reduced concomitantly to levels where marker determinations would be of little use. The study demonstrated a possible, but limited role for preoperative determinations of the markers. A combination of two or three markers was not superior to single markers. The results indicate that neither of these markers will be of significant value in a screening context.

摘要

对42例良性、17例交界性和53例恶性上皮性卵巢肿瘤患者在剖腹手术前采集血样。测定CA - 125、组织多肽抗原和胎盘碱性磷酸酶(PLAP)的浓度。CA - 125和TPA水平之间未发现显著差异。肿瘤类型与这两种标志物之间无显著相关性;然而,两者均与肿瘤恶性程度和临床分期显著相关,且CA - 125也与肿瘤分级相关。未发现PLAP与其他标志物或上述任何参数之间存在相关性。如果要求两种或三种标志物中至少有一种为阳性,则恶性肿瘤的“检出率”有适度提高。然而,良性样本的阳性率高达41%。要求两种或三种标志物中至少两种为阳性确实减少了“假阳性”良性肿瘤的数量,但恶性肿瘤的敏感性也随之降低到标志物检测几乎无用的水平。该研究表明术前测定这些标志物可能有一定作用,但作用有限。两种或三种标志物联合使用并不优于单一标志物。结果表明,在筛查方面,这些标志物均无显著价值。

相似文献

1
CA-125, placental alkaline phosphatase and tissue polypeptide antigen as preoperative serum markers in ovarian carcinoma.CA-125、胎盘碱性磷酸酶和组织多肽抗原作为卵巢癌术前血清标志物
Gynecol Obstet Invest. 1992;33(3):177-82. doi: 10.1159/000294876.
2
Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis.卵巢癌、交界性肿瘤或良性附件肿块患者的CA-125、癌胚抗原、组织多肽抗原和胎盘碱性磷酸酶的预处理血清水平:对鉴别诊断的意义。
Gynecol Oncol. 1990 Oct;39(1):16-25. doi: 10.1016/0090-8258(90)90393-y.
3
Placental alkaline phosphatase (PLAP)/PLAP-like alkaline phosphatase as tumour marker in relation to CA 125 and TPA for ovarian epithelial tumours.胎盘碱性磷酸酶(PLAP)/类PLAP碱性磷酸酶作为与CA 125和组织多肽抗原相关的卵巢上皮性肿瘤的肿瘤标志物
Eur J Gynaecol Oncol. 1990;11(5):351-60.
4
Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase in patients with ovarian carcinoma: influence of histological type, grade of differentiation, and clinical stage of disease.
Gynecol Oncol. 1990 Oct;39(1):26-33. doi: 10.1016/0090-8258(90)90394-z.
5
CA 125, placental alkaline phosphatase, and tissue polypeptide antigen in the monitoring of ovarian carcinoma. A comparative study of three different tumor markers.CA 125、胎盘碱性磷酸酶及组织多肽抗原在卵巢癌监测中的应用。三种不同肿瘤标志物的比较研究。
Gynecol Obstet Invest. 1990;30(3):178-83. doi: 10.1159/000293261.
6
Comparison of CA 125 and placental alkaline phosphatase as ovarian tumor markers.CA 125与胎盘碱性磷酸酶作为卵巢肿瘤标志物的比较。
Tumori. 1987 Jun 30;73(3):301-2. doi: 10.1177/030089168707300315.
7
[Value of CA 125 in comparison to conventional tumor markers in ovarian cancer].[CA 125在卵巢癌中与传统肿瘤标志物相比的价值]
Geburtshilfe Frauenheilkd. 1986 Aug;46(8):509-14. doi: 10.1055/s-2008-1036246.
8
[Tumor-associated antigens and fibrin derivatives as reaction products of ovarian cancer].
Geburtshilfe Frauenheilkd. 1986 Jan;46(1):1-10. doi: 10.1055/s-2008-1036152.
9
[New prospects in the combined use of tumor markers in epithelial neoplasms of the ovary].
Ann Ostet Ginecol Med Perinat. 1991 Jan-Feb;112(1):36-40.
10
Tumor markers in bronchogenic carcinoma. An evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase and pseudouridine.支气管源性癌中的肿瘤标志物。癌胚抗原、组织多肽抗原、胎盘碱性磷酸酶及假尿苷的评估
Acta Radiol Oncol. 1983;22(3):209-14. doi: 10.3109/02841868309134033.

引用本文的文献

1
D-amino acid-containing supramolecular nanofibers for potential cancer therapeutics.用于潜在癌症治疗的含D-氨基酸超分子纳米纤维
Adv Drug Deliv Rev. 2017 Feb;110-111:102-111. doi: 10.1016/j.addr.2016.04.008. Epub 2016 Apr 19.